Can I Take Vitamin B6 with Cialis (Tadalafil)?

The Short Answer: No Meaningful Interaction at Standard Doses

Vitamin B6 and tadalafil do not share a recognized pharmacokinetic interaction pathway. Tadalafil is metabolized primarily by hepatic CYP3A4 [1], and vitamin B6 at supplemental doses does not meaningfully inhibit or induce that enzyme system. There is no documented pharmacodynamic overlap either, B6 does not affect phosphodiesterase-5 activity, blood pressure in a clinically significant way, or penile smooth-muscle relaxation pathways.

Why Interaction Questions Arise

The question comes up because tadalafil carries a well-known interaction list involving nitrates, alpha-blockers, and CYP3A4 inhibitors such as ketoconazole and ritonavir [1]. Patients reasonably wonder whether a supplement could add to that list. B6 does not belong on it for the reasons detailed below.

A second reason the question surfaces is that high-dose B6 causes peripheral neuropathy [2], and neuropathy can affect sexual function. Men researching the overlap between nerve health and ED may assume the two interact clinically. They do not interact pharmacologically, but both issues can affect the same patient.

What the FDA Prescribing Information Says

The Cialis (tadalafil) U.S. Prescribing information lists the following as meaningful drug interactions: potent CYP3A4 inhibitors, nitrates, antihypertensives (especially alpha-blockers and amlodipine), and other PDE5 inhibitors [1]. Vitamin B6 appears nowhere in that document. The FDA's 2024 updated label for tadalafil 2.5 mg, 20 mg tablets does not flag any vitamin or micronutrient interaction [1].

How Tadalafil Is Metabolized

Tadalafil's pharmacokinetics have been well characterized in regulatory submissions and clinical pharmacology studies. Understanding the metabolism pathway explains why most supplements, including B6, do not alter tadalafil exposure.

CYP3A4 as the Primary Elimination Route

After oral absorption, tadalafil undergoes hepatic oxidation via CYP3A4 to a catechol metabolite, which is then methylated to a methyl catechol glucuronide, the major circulating metabolite, pharmacologically inactive [1]. No other cytochrome P450 isoform contributes substantially to its clearance [3].

This matters because any compound that neither inhibits nor induces CYP3A4 will not alter tadalafil's area under the curve (AUC) or peak plasma concentration (Cmax) in a clinically meaningful way. Ketoconazole 400 mg/day raised tadalafil AUC by 312% in a crossover study [1], an example of what strong CYP3A4 inhibition looks like. Vitamin B6 produces no comparable effect.

Protein Binding and Renal Clearance

Tadalafil is approximately 94% protein-bound, primarily to albumin [1]. Renal excretion accounts for roughly 36% of the oral dose as metabolites, with the remainder eliminated in feces [1]. Vitamin B6 compounds are water-soluble and do not compete meaningfully for albumin binding sites at physiologic concentrations [4]. Pyridoxal-5-phosphate (PLP), the active coenzyme form, circulates at nanomolar concentrations in adequately nourished adults, far too low to displace a drug with high protein-binding affinity [4].

How Vitamin B6 Is Processed in the Body

Vitamin B6 is a collective term for three naturally occurring forms: pyridoxine (PN), pyridoxal (PL), and pyridoxamine (PM), plus their phosphorylated derivatives [2]. All are converted to PLP in the liver and intestinal mucosa.

Absorption and Conversion to PLP

Dietary B6 is absorbed in the jejunum by passive diffusion. After phosphorylation, pyridoxal-5-phosphate is the coenzyme that participates in more than 100 enzymatic reactions involving amino acid metabolism, neurotransmitter synthesis, and heme production [2]. PLP does not directly modulate vascular smooth muscle tone, nitric oxide synthase activity at pharmacologic doses, or cGMP pathways in the way that would create overlap with PDE5 inhibition [5].

Elimination Half-Life and Storage

The biological half-life of PLP in plasma is approximately 25 days at tissue saturation [2]. This prolonged retention is why chronic high-dose supplementation is more hazardous than acute single-dose exposure. B6 is not stored in fat; it is not lipophilic. Its elimination does not depend on CYP3A4 or other enzymes that tadalafil uses [2].

The High-Dose B6 Neuropathy Risk

This is the most clinically significant concern for any patient taking B6, regardless of what other medications they use.

Sensory Neuropathy: Mechanism and Evidence

Sustained high-dose pyridoxine causes a sensory neuronopathy by direct toxicity to dorsal root ganglia. The condition was first described systematically by Schaumburg et al. In 1983, when seven patients taking 2,000 to 6,000 mg/day of pyridoxine developed severe ataxia and sensory loss [6]. Later case series confirmed neuropathy at doses as low as 200 mg/day with chronic use spanning months to years [6].

The European Food Safety Authority (EFSA) reviewed the dose-response relationship in 2023 and set a tolerable upper intake level of 12.5 mg/day for adults, citing emerging data that subclinical neurophysiologic changes may begin below 100 mg/day in susceptible individuals [7]. The U.S. Institute of Medicine's older Tolerable Upper Intake Level (UL) of 100 mg/day for adults remains the reference used in most U.S. Clinical guidelines [8].

What "High Dose" Actually Means in Practice

Many off-the-shelf B6 supplements sold in the United States contain 50 to 100 mg per capsule, placing single-pill doses at the boundary of the U.S. UL. "B-complex 100" formulas routinely contain 100 mg of B6 per serving. Patients taking multiple B-complex products simultaneously may unknowingly exceed 200 mg/day, the threshold at which neuropathy cases cluster in the literature [6].

Symptoms include:

• Tingling or burning in the feet and hands
• Difficulty with balance or proprioception
• Reduced vibration sense on neurologic examination

Recovery after stopping high-dose B6 is usually gradual. In a case series of 23 patients, sensory function improved over six to 24 months after discontinuation, but some residual deficit persisted in patients who had taken very high doses for years [6].

Does Tadalafil Worsen B6 Neuropathy?

No pharmacologic mechanism links tadalafil to worsening pyridoxine neuropathy. Tadalafil does not alter B6 metabolism, does not affect dorsal root ganglion tissue directly, and is not associated with peripheral neuropathy in its prescribing information or post-marketing data [1]. However, a clinician evaluating new-onset tingling in a man taking both agents should check B6 levels first, before attributing symptoms to tadalafil or any vascular cause.

When B6 Is Specifically Needed Alongside Other Drugs

Some patients require concurrent B6 supplementation for a distinct clinical reason unrelated to tadalafil. Isoniazid (for tuberculosis treatment), cycloserine, and hydralazine each deplete pyridoxal-5-phosphate by forming stable complexes with the coenzyme [9]. Standard practice for isoniazid therapy is co-prescription of pyridoxine 25 to 50 mg/day to prevent drug-induced peripheral neuropathy [9].

If such a patient also takes tadalafil for ED or BPH, there is still no pharmacokinetic interaction between tadalafil and the B6 supplement. The B6 corrects a drug-induced deficiency without altering tadalafil exposure. Dose selection in this context should target the minimum effective B6 dose, typically 25 to 50 mg/day, rather than the higher "general wellness" doses sometimes marketed for energy or PMS relief [9].

Tadalafil's Actual Drug Interaction Concerns

To place the B6 question in context, here are the interactions that do require clinical attention.

CYP3A4 Inhibitors

Ritonavir 200 mg twice daily increased tadalafil AUC by 124% and Cmax by 110% in a pharmacokinetic study [1]. Ketoconazole 400 mg/day produced a 312% AUC increase [1]. Erythromycin 500 mg three times daily increased tadalafil AUC by 182% [1]. These interactions are managed by dose reduction or avoidance.

Nitrates and Alpha-Blockers

Tadalafil potentiates the hypotensive effect of nitrates through additive cGMP-mediated smooth muscle relaxation; concurrent use is contraindicated [1]. Alpha-blockers such as tamsulosin may also produce additive hypotension, though tamsulosin 0.4 mg is the exception least likely to cause symptomatic hypotension when co-administered with tadalafil 20 mg [1].

Antihypertensives

In clinical pharmacology studies, tadalafil 20 mg with amlodipine 5 mg or 10 mg produced a mean additional 8 mmHg reduction in systolic blood pressure [1]. Patients on antihypertensives should begin tadalafil at the lowest available dose (2.5 mg for daily use).

None of these interactions involve vitamin supplementation. The contrast helps clarify that B6 belongs in a genuinely different risk category.

Nitric Oxide, B6, and the Vascular Connection

Some supplement marketing claims that B6 supports nitric oxide (NO) production and therefore enhances the effects of PDE5 inhibitors. Here is what the evidence actually shows.

PLP participates in the synthesis of serine and glycine, and indirectly supports cysteine availability, which is a substrate for hydrogen sulfide signaling with some vasodilatory properties [5]. However, the magnitude of this effect at supplemental doses is not clinically significant. No randomized controlled trial has demonstrated that vitamin B6 supplementation enhances erections or potentiates tadalafil's hemodynamic effects [5].

The claim that B6 "boosts" NO pathways sufficiently to meaningfully interact with a PDE5 inhibitor is not supported by available human trial data. Patients should not take high doses of B6 expecting enhanced ED treatment, and they should not avoid standard B6 supplementation out of fear of additive hypotension that has not been demonstrated.

Homocysteine, Cardiovascular Risk, and the B6-ED Connection

Elevated homocysteine is a risk factor for endothelial dysfunction, which underlies vascular ED [10]. B vitamins, specifically folate (B9), B12, and B6, are cofactors in homocysteine remethylation and transsulfuration pathways [10]. Lowering homocysteine with B vitamins has been hypothesized to improve endothelial function and indirectly benefit erectile function.

The HOPE-2 trial (N=5,522) showed that B-vitamin supplementation (including folic acid 2.5 mg, B6 50 mg, and B12 1 mg daily) reduced plasma homocysteine by 25% over five years but did not significantly reduce cardiovascular events [11]. A 2017 Cochrane review of 15 trials (N=71,422) similarly found no statistically significant reduction in myocardial infarction or all-cause mortality from homocysteine-lowering B-vitamin therapy [12].

The clinical takeaway: B6 at 50 mg/day has a legitimate biochemical rationale in men with elevated homocysteine and vascular ED, but the evidence for a meaningful clinical outcome benefit is weak. It does not interact with tadalafil pharmacologically, and it does not substitute for it therapeutically.

Practical Dosing Guidance for Men Taking Both

Dietary Intake First

The recommended dietary allowance (RDA) for B6 in adult men is 1.3 mg/day, rising to 1.7 mg/day for men over 50 [8]. Most men consuming adequate protein from poultry, fish, potatoes, and non-citrus fruits meet this threshold from food alone [8]. Supplementation is not necessary for the majority.

When Supplementation Is Appropriate

Supplementation may be appropriate for men with documented B6 deficiency (plasma PLP <20 nmol/L), those on isoniazid or cycloserine, those with malabsorptive conditions, or strict vegans with limited dietary variety [9]. In these cases, 25 to 50 mg/day is effective and keeps intake comfortably below the U.S. UL of 100 mg/day [8].

What to Avoid

Doses above 100 mg/day are unnecessary for most adults and carry an escalating neuropathy risk with prolonged use [6][7]. The EFSA 2023 position considers even 12.5 mg/day as the maximum safe level based on updated neurophysiologic data in sensitive individuals [7]. Taking tadalafil does not change this calculus, the neuropathy risk is B6-dose-dependent, not tadalafil-dependent.

Timing

No dose-separation window is required between tadalafil and B6. They do not interact pharmacokinetically. Tadalafil's 17.5-hour half-life means separating doses by a few hours would not reduce any theoretical interaction even if one existed [1].

When to Talk to Your Doctor

Contact your prescribing clinician before combining tadalafil with any supplement if:

• You are taking a CYP3A4 inhibitor (including grapefruit juice in large quantities, ritonavir, ketoconazole, or itraconazole)
• You are on antihypertensives or nitrates
• You notice new peripheral numbness or tingling after starting any B6 product
• The B6 product you are using contains more than 100 mg per serving

Plasma PLP testing (reference range: 20 to 125 nmol/L) can confirm whether supplementation is actually needed and guide dose selection [4].